Overcoming COVID-19 Vaccine Hesitancy and Barriers
Date: Wednesday, February 17, 2021
Time: 11:00 AM ET
Although initial demand for COVID-19 vaccines is high, inequitable vaccine distribution and vaccine reluctance among historically marginalized populations may amplify the disease’s disparate outcomes in the hardest-hit communities.
Vaccine hesitancy exists in the general public as well as among health care professionals. Roughly 40 percent of employees at association member Wellforce, in Burlington, Mass., have declined the COVID-19 vaccine. participants explored how Wellforce leverages linguistically and culturally competent physician outreach and community partnerships to respond to the concerns of staff, patients, and the public.
Rosa Colon-Kolacko, PhD, MBA
Vice President and Chief Diversity, Equity, and Inclusion Officer
Jennifer Stephens, MPH
America’s Essential Hospitals
Gabriela Andujar Vazquez, MD
Attending Physician and Assistant Professor
Tufts University School of Medicine
Adam Weston, MD
Medical Director, Antimicrobial Stewardship Program
Lowell General Hospital